{
  "ticker": "INSM",
  "company_name": "Insmed Incorporated",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03218917",
      "title": "Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Non-Cystic Fibrosis Bronchiectasis",
      "start_date": "2017-10-31",
      "completion_date": "2019-12-12",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT00678015",
      "title": "Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Prostate Cancer",
      "start_date": "2008-05",
      "completion_date": "2011-06",
      "enrollment": 0,
      "sponsor": "University of California, San Francisco"
    },
    {
      "nct_id": "NCT00777296",
      "title": "Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE\u2122)",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Cystic Fibrosis",
      "start_date": "2007-02-22",
      "completion_date": "2008-02-27",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT05344508",
      "title": "An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis",
      "status": "APPROVED_FOR_MARKETING",
      "phase": "",
      "condition": "Non-Cystic Fibrosis Bronchiectasis",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT05355935",
      "title": "A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2022-04-27",
      "completion_date": "2022-10-07",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT04677543",
      "title": "Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Mycobacterium Infections, Nontuberculous",
      "start_date": "2020-12-22",
      "completion_date": "2023-05-09",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT01315678",
      "title": "Study to Evaluate Arikayce\u2122 in CF Patients With Chronic Pseudomonas Aeruginosa Infections",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Pseudomonas Aeruginosa Infection",
      "start_date": "2012-02-29",
      "completion_date": "2013-09-18",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT04594369",
      "title": "A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Non-Cystic Fibrosis Bronchiectasis",
      "start_date": "2020-12-01",
      "completion_date": "2024-10-28",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT00368173",
      "title": "IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Insmed Incorporated"
    },
    {
      "nct_id": "NCT04817332",
      "title": "STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Covid19",
      "start_date": "2020-06-05",
      "completion_date": "2021-02-28",
      "enrollment": 0,
      "sponsor": "University of Dundee"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE2": 14,
      "PHASE1, PHASE2": 3,
      "": 3,
      "PHASE1": 16,
      "PHASE3": 11,
      "PHASE2, PHASE3": 3
    },
    "by_status": {
      "COMPLETED": 35,
      "TERMINATED": 3,
      "APPROVED_FOR_MARKETING": 1,
      "NOT_YET_RECRUITING": 2,
      "RECRUITING": 3,
      "WITHDRAWN": 1,
      "ACTIVE_NOT_RECRUITING": 4,
      "AVAILABLE": 1
    },
    "active_trials": 7,
    "completed_trials": 35,
    "conditions": [
      "Amyotrophic Lateral Sclerosis",
      "Bronchiectasis",
      "Bronchiectasis, Non-Tuberculous Mycobacterial Pneumonia",
      "Chronic Rhinosinusitis Without Nasal Polyps",
      "Covid19",
      "Cystic Fibrosis",
      "Duchenne Muscular Dystrophy",
      "Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome",
      "Healthy Participants",
      "Healthy Volunteer",
      "Healthy Volunteers",
      "Hepatic Impairment",
      "Hidradenitis Suppurativa",
      "Mycobacterium Infections, Nontuberculous",
      "Mycobacterium Infections, Nontuberculous, Mycobacteria, Atypical",
      "Myotonic Dystrophy Type 1",
      "NTM Lung Infection Due to MAC",
      "Non-Cystic Fibrosis Bronchiectasis",
      "Noonan Syndrome",
      "Osteosarcoma Metastatic",
      "Prostate Cancer",
      "Pseudomonas Aeruginosa Infection",
      "Pulmonary Arterial Hypertension",
      "Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease",
      "Pulmonary Hypertension",
      "Pulmonary Hypertension, Interstitial Lung Disease",
      "Renal Impairment"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:08.407197",
    "search_query": "Insmed Incorporated",
    "url": "https://clinicaltrials.gov/search?term=Insmed+Incorporated"
  }
}